"
In Frail Elderly Patients, Low-Dose Gemcitabine over 6-Hour Infusion Is Equally Effective and Less Toxic Than the Standard Gemcitabine Protocol for Advanced Pancreatic Adenocarcinoma: A Randomized Phase II Trial"
written by Salah Mabrouk Khallaf, Elsayed Mostafa Ali, Ahmed M. Maklad, Mohamed Medhat Samir, Anwar Tawfik Amin, Muhammad Abbas El-Masry, Mona M. Sayed, Dalia Osama,
published by
Journal of Cancer Therapy,
Vol.11 No.3, 2020
has been cited by the following article(s):